Genomic screening of testicular germ cell tumors from monozygotic twins

Abstract

BackgroundTesticular germ cell tumors (TGCTs) account for 1-2% of all tumors in young and middle aged men. A 75-fold increase in TCGT development has been reported for monozygotic (MZ) twins. Therefore, the occurrence of simultaneous tumors in MZ twins emphasizes the importance of genetic factors that influence the risk of developing these tumors. Genomic screening was performed for one family containing MZ twins with testicular germ cell tumors, in order to define alterations associated with risk of tumor development.MethodsCopy number alterations were evaluated using array-CGH (4x44K, Agilent Technologies) in one seminoma and one embryonal carcinoma (EC) from MZ twins. In addition, genomic alterations from the tumors and peripheral blood cells of the twins were compared to the parental genomes via their peripheral blood cells.ResultsEmbryonal carcinoma (Twin-1 t) presented a lower frequency of genomic alterations compared to the seminoma (Twin-2 t). One minimal common region of loss was observed in 9p13.1-p12 in the comparison between DNA from blood samples for Twin-1 and Twin-2. In this region is mapped the CNTNAP3 gene which was confirmed as involved in losses by qPCR. Comparative analysis of novel CNVs between the Twin-1 t and Twin-2 t showed five minimal common regions involving gain at chromosomes 12 (12p12.3-p11.1 and 12p13.33-p12.3), while losses were observed at 10p15.3-p15.2, 13q21.1-q21.2 and 15q11.1-q11.2. In addition, one exclusive rare copy number alteration was detected in Twin-1 t and Twin-2 t, and 19 novel alterations were identified in the Twin-2 t.ConclusionDistinct genomic profiles for MZ twins with phenotypically different TGCT were described. Of particular interest, 12p gains were detected exclusively in tumor samples. In peripheral blood samples, loss of 9p13.1-p12 was the unique novel CNV shared by the twins, confirming the involvement of CNTNAP3 gene in TGCTs development. Although similar CNV profiles were shared by both the peripheral blood and tumor samples of the twins, tumor-specific CNV loci were identified for seminoma and non-seminomatous tumors. These findings suggest the presence of de novo germline structural alterations and TGCT predisposition.Electronic supplementary materialThe online version of this article (doi:10.1186/s13023-014-0181-x) contains supplementary material, which is available to authorized users.

RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR

“…Copy number variation is a common mechanism by which the expression levels of genes that contribute to cancer development are regulated [ 13 , 14 ], and contributes to the development of gastric cancer [ 15 ], ovarian cancer [ 16 ], hepatocellular carcinoma [ 17 ], testicular germ cell tumors [ 18 ], colorectal carcinoma [ 19 ], and bladder cancer [ 20 ]. Copies of apoptosis effector genes are often lost during cancer development, in contrast with the frequent amplification of proliferation-related genes [ 21 ].…”

Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy

“…12 DNA CNVs include gene amplification, gain, loss and deletion. In addition to gene mutation, CNV has a significant role in tumorigenesis in many cancers, such as GC, 13 ovarian cancer, 14 hepatocellular carcinoma, 15 testicular germ cell tumors, 16 colorectal carcinoma, 17 bladder cancer 18 and so on. The accumulation of CNVs during gastric oncogenesis may be a result of preferential selection by which transforming cells gain evolutionary advantage.…”

Developmental genes significantly afflicted by aberrant promoter methylation and somatic mutation predict overall survival of late-stage colorectal cancer

“…It is putatively accredited that carcinogenesis is caused by multi-level dysregulations, including genomics [majorly caused by somatic mutation and copy number variation (CNV)] 4 5 , DNA methylomics 6 7 , and transcriptomics 8 9 . CNV plays a significant role in tumorigenesis in many cancers 10 11 12 13 14 , whose accumulation during oncogenesis might be a result of preferential selection by which transforming cells gain evolutionary advantages 15 . Somatic mutation, together with CNV, could contribute to genomic instability 4 .…”